Related Experiment Video
Updated: May 12, 2026
09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Proteomic characterization of human platelet-derived microparticles.
Anna Laura Capriotti1, Giuseppe Caruso, Chiara Cavaliere
1Dipartimento di Chimica, Sapienza Università di Roma, Rome, Italy. annalaura.capriotti@uniroma1.it
Analytica Chimica Acta
|April 23, 2013
Summary
Researchers identified 603 proteins in platelet-derived microparticles (PMPs), including 243 novel proteins. This advance aids understanding of PMP roles in disease and biomarker discovery.
Area of Science:
- Proteomics
- Cell Biology
- Biochemistry
Background:
- Microparticles (MPs) are cell fragments implicated in various diseases.
- Platelet-derived microparticles (PMPs) are the most prevalent MPs in human blood.
- Characterizing PMP proteins is crucial for understanding their pathological roles.
Purpose of the Study:
- To comprehensively identify proteins within PMPs.
- To develop an improved proteomic strategy for low-abundance protein detection.
- To establish a foundation for PMP-related biomarker discovery.
Main Methods:
- Shotgun proteomics using nano-HPLC and LTQ Orbitrap XL mass spectrometry.
- PMPs were generated from adenosine diphosphate (ADP)-stimulated platelets.
- A two-step analytical platform incorporating hydrogel nanoparticle fractionation for enhanced low-molecular weight and low-abundance protein identification.
Main Results:
- Identification of 603 unique proteins in PMPs.
- Discovery of 243 previously unidentified proteins.
- Development of a robust analytical method for PMP proteomic analysis.
Conclusions:
- The study provides a refined proteomic approach for PMP analysis.
- The identified protein dataset offers insights into PMP biological and pathological functions.
- This work serves as a baseline for future biomarker research in diseases involving PMPs.
